SEC Form D · filed December 21, 2022
NLS Pharmaceutics Ltd
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Ronald Hafner · Zurich, V8DirectorGian-Marco Rinaldi De La Cruz · Zurich, V8DirectorMyoung-Ok Kwon · Zurich, V8DirectorAlexander Zwyer · Zurich, V8ExecChad Hellmann · Zurich, V8ExecStig Lokke Pedersen · Zurich, V8DirectorMargaret Sprenger · Ridgefield, CTDirectorDoron Breen · TEL AVIV, L3DirectorAsuna P. Gilfoyle · NEW YORK, NYExecGary D. Edmonds · Wayne, PADirectorLisa Sun · New York, NYDirectorPeter Ackerson · Ridgefield, CTExecMartin Lehr · Arlington, MADirectorDhvani D. Shah · Winnipeg, Manitoba, CanadaExecLinda D. Kerrigan · Winnipeg, Manitoba, CanadaDirectorPaul A. Mahon · Winnipeg, Manitoba, CanadaExecAmy A. Metzger · Winnipeg, Manitoba, CanadaDirectorFabrice A. Morin · Winnipeg, Manitoba, CanadaDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗